speb/financial-data huggingface dataset:
CBAT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 88645836.00
CBAT balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 337715.00
CBAT balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 2287144.00
CBAT balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -8300352.00
CBAT balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 7955358.00
CBAT income_statement (quarterly, 2026-03-31) — Other Gand A: 4510224.00
CBAT income_statement (quarterly, 2026-03-31) — Other Income Expense: 1149616.00
CBAT balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 12474244.00
CBAT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 2068069.00
CBAT balance_sheet (quarterly, 2026-03-31) — Other Payable: 186045774.00
CBAT balance_sheet (quarterly, 2026-03-31) — Other Properties: 2920127.00
CBAT balance_sheet (quarterly, 2026-03-31) — Other Receivables: 3778301.00
CBAT balance_sheet (quarterly, 2026-03-31) — Payables: 274769263.00
CBAT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 289277872.00
CBAT balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 2102809.00
CBAT income_statement (quarterly, 2026-03-31) — Pretax Income: -8954864.00
CBAT balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CBAT cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 48817.00
CBAT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -11784371.00
CBAT balance_sheet (quarterly, 2026-03-31) — Raw Materials: 15364191.00
CBAT balance_sheet (quarterly, 2026-03-31) — Receivables: 61635854.00
CBAT balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -17592.00
CBAT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 68578124.00
CBAT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3680954.00
CBAT cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -11937817.00
CBAT income_statement (quarterly, 2026-03-31) — Research And Development: 4219925.00
CBAT balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 89257922.00
CBAT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -143083312.00
CBAT income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1998104.00
CBAT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 6508328.00
CBAT balance_sheet (quarterly, 2026-03-31) — Share Issued: 88645836.00
CBAT income_statement (quarterly, 2026-03-31) — Special Income Charges: -12198.00
CBAT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 443.00
CBAT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 105160959.00
CBAT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 92686715.00
CBAT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -367381.20
CBAT income_statement (quarterly, 2026-03-31) — Tax Provision: 7426.00
CBAT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CBAT balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 11203830.00
CBAT balance_sheet (quarterly, 2026-03-31) — Total Assets: 491005544.00
CBAT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 112813319.00
CBAT balance_sheet (quarterly, 2026-03-31) — Total Debt: 51006605.00
CBAT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 102208772.00
CBAT income_statement (quarterly, 2026-03-31) — Total Expenses: 79306377.00
CBAT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 388796772.00
CBAT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 252579768.00
CBAT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 20593912.00
CBAT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -9700583.00
CBAT income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 416095.00
CBAT balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1107311.00
CBAT income_statement (quarterly, 2026-03-31) — Total Unusual Items: -918453.00
CBAT income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -918453.00
CBAT balance_sheet (quarterly, 2026-03-31) — Work In Process: 23410581.00
CBAT balance_sheet (quarterly, 2026-03-31) — Working Capital: -129777084.00
CBAT income_statement (quarterly, 2026-03-31) — Write Off: 12198.00
CBAV.MC balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 1653618.00
CBAV.MC balance_sheet (annual, 2021-12-31) — Net Debt: 925027.00
CBAV.MC balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 644774.00
CBAV.MC balance_sheet (annual, 2021-12-31) — Other Equity Interest: -8151845.00
CBAV.MC balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 644774.00
CBAV.MC balance_sheet (annual, 2021-12-31) — Other Payable: 2739426.00
CBAV.MC income_statement (annual, 2022-12-31) — +Operating Expense: 130832476.00
CBAV.MC income_statement (annual, 2022-12-31) — +Total Revenue: 198449250.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Accounts Payable: 15621896.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Accounts Receivable: 2844011.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -124338573.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 4893814.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -362363.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 3205882.00
CBAV.MC income_statement (annual, 2022-12-31) — Basic Average Shares: 16303008.00
CBAV.MC income_statement (annual, 2022-12-31) — Basic EPS: 1.81
CBAV.MC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 9801026.00
CBAV.MC cash_flow (annual, 2022-12-31) — Capital Expenditure: -14030676.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 43247222.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Capital Stock: 1630758.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 19172895.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 38990067.00
CBAV.MC cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -17188314.00
CBAV.MC cash_flow (annual, 2022-12-31) — Change In Inventory: -228578.00
CBAV.MC cash_flow (annual, 2022-12-31) — Change In Payable: 5015636.00
CBAV.MC cash_flow (annual, 2022-12-31) — Change In Receivables: 176398.00
CBAV.MC cash_flow (annual, 2022-12-31) — Change In Working Capital: 4963456.00
CBAV.MC cash_flow (annual, 2022-12-31) — Changes In Cash: 9371870.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Common Stock: 1630758.00
CBAV.MC cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -17188314.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 67344261.00
CBAV.MC cash_flow (annual, 2022-12-31) — Common Stock Issuance: 596930.00
CBAV.MC cash_flow (annual, 2022-12-31) — Common Stock Payments: -617398.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Construction In Progress: 5000078.00
CBAV.MC income_statement (annual, 2022-12-31) — Cost Of Revenue: 25501559.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Current Assets: 44608763.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 7834923.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Current Debt: 2106422.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 9941345.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Current Liabilities: 41038693.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Current Provisions: 1068652.00
CBAV.MC cash_flow (annual, 2022-12-31) — Depreciation: 14997110.00
CBAV.MC cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 14997110.00
CBAV.MC income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 14997110.00
CBAV.MC income_statement (annual, 2022-12-31) — Depreciation Income Statement: 14997110.00
CBAV.MC income_statement (annual, 2022-12-31) — Diluted Average Shares: 16303008.00
CBAV.MC income_statement (annual, 2022-12-31) — Diluted EPS: 1.81
CBAV.MC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 29518528.00
CBAV.MC income_statement (annual, 2022-12-31) — EBIT: 41098766.00
CBAV.MC income_statement (annual, 2022-12-31) — EBITDA: 56095876.00
CBAV.MC cash_flow (annual, 2022-12-31) — End Cash Position: 19172895.00
CBAV.MC cash_flow (annual, 2022-12-31) — Financing Cash Flow: -31446446.00
CBAV.MC cash_flow (annual, 2022-12-31) — Free Cash Flow: 39346396.00
CBAV.MC income_statement (annual, 2022-12-31) — General And Administrative Expense: 18344263.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Goodwill: 14615838.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 15076926.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 3206374.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Gross PPE: 210417863.00
CBAV.MC income_statement (annual, 2022-12-31) — Gross Profit: 172947691.00
CBAV.MC income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 467407.00
CBAV.MC income_statement (annual, 2022-12-31) — Interest Expense: 418832.00
CBAV.MC income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 418832.00
CBAV.MC income_statement (annual, 2022-12-31) — Interest Income: 67214.00
CBAV.MC income_statement (annual, 2022-12-31) — Interest Income Non Operating: 67214.00
CBAV.MC cash_flow (annual, 2022-12-31) — Interest Paid Cff: -456315.00
CBAV.MC cash_flow (annual, 2022-12-31) — Interest Received Cfi: 67214.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Inventory: 2161524.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Invested Capital: 72011052.00
CBAV.MC cash_flow (annual, 2022-12-31) — Investing Cash Flow: -12558756.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 3205882.00
CBAV.MC cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 596930.00
CBAV.MC cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 35412299.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Long Term Debt: 2560369.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 37972668.00
CBAV.MC cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CBAV.MC cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -6052605.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 122195.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2464263.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 100618024.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Minority Interest: 1023607.00
CBAV.MC income_statement (annual, 2022-12-31) — Minority Interests: -628281.00
CBAV.MC cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CBAV.MC cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -20468.00
CBAV.MC income_statement (annual, 2022-12-31) — Net Income: 29518528.00
CBAV.MC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 29518528.00
CBAV.MC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 30146809.00
CBAV.MC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 29518528.00
CBAV.MC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 29518528.00
CBAV.MC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 40679934.00
CBAV.MC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 30146809.00
CBAV.MC income_statement (annual, 2022-12-31) — Net Interest Income: -351618.00
CBAV.MC cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 1404706.00
CBAV.MC cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -6052605.00
CBAV.MC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -6052605.00
CBAV.MC income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -351618.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Net PPE: 86079289.00
CBAV.MC cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -14030676.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 52267335.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 1010558.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 260121.00
CBAV.MC income_statement (annual, 2022-12-31) — Normalized EBITDA: 56966827.00
CBAV.MC income_statement (annual, 2022-12-31) — Normalized Income: 30163966.45
CBAV.MC cash_flow (annual, 2022-12-31) — Operating Cash Flow: 53377072.00
CBAV.MC income_statement (annual, 2022-12-31) — Operating Income: 42115215.00
CBAV.MC income_statement (annual, 2022-12-31) — Operating Revenue: 198449250.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 16302384.00
CBAV.MC cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: -1.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Other Current Assets: 584416.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Other Equity Interest: -8151564.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 461088.00
CBAV.MC cash_flow (annual, 2022-12-31) — Other Non Cash Items: 755162.00
CBAV.MC income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -155336.00
CBAV.MC income_statement (annual, 2022-12-31) — Other Operating Expenses: 15041161.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Other Payable: 3536107.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Other Properties: 5928130.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Other Receivables: 28315.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 19817172.00
CBAV.MC income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Payables: 20230199.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 875530.00
CBAV.MC income_statement (annual, 2022-12-31) — Pretax Income: 40679934.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Properties: 98871631.00
CBAV.MC cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 964669.00
CBAV.MC cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CBAV.MC cash_flow (annual, 2022-12-31) — Purchase Of Investment: -24515901.00
CBAV.MC cash_flow (annual, 2022-12-31) — Purchase Of PPE: -14030676.00
CBAV.MC income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 25501559.00
CBAV.MC income_statement (annual, 2022-12-31) — Reconciled Depreciation: 14997110.00
CBAV.MC income_statement (annual, 2022-12-31) — Rent And Landing Fees: 1824116.00
CBAV.MC income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 1824116.00
CBAV.MC cash_flow (annual, 2022-12-31) — Repayment Of Debt: -6052605.00
CBAV.MC cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -617398.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Retained Earnings: 29518528.00
CBAV.MC cash_flow (annual, 2022-12-31) — Sale Of Investment: 25920607.00
CBAV.MC income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 9862169.00
CBAV.MC income_statement (annual, 2022-12-31) — Selling General And Administration: 28206432.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Share Issued: 16307580.00
CBAV.MC income_statement (annual, 2022-12-31) — Special Income Charges: -467407.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 67344261.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Tangible Book Value: 52267335.00
CBAV.MC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -225512.55
CBAV.MC income_statement (annual, 2022-12-31) — Tax Provision: 10533125.00
CBAV.MC income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CBAV.MC balance_sheet (annual, 2022-12-31) — Taxes Receivable: 430.00
CBAV.MC cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -9628264.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Total Assets: 150103613.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Total Capitalization: 69904630.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Total Debt: 47914013.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 68367868.00
CBAV.MC income_statement (annual, 2022-12-31) — Total Expenses: 156334035.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 81735745.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 105494850.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 40697052.00
CBAV.MC income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 41492472.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Total Tax Payable: 4608303.00
CBAV.MC income_statement (annual, 2022-12-31) — Total Unusual Items: -870951.00
CBAV.MC income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -870951.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 5196.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Treasury Stock: 93678.00
CBAV.MC balance_sheet (annual, 2022-12-31) — Working Capital: 3570070.00
CBAV.MC income_statement (annual, 2023-12-31) — +Operating Expense: 147809275.00
CBAV.MC income_statement (annual, 2023-12-31) — +Total Revenue: 224923951.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Accounts Payable: 15524293.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2951838.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -135089095.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 4893814.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -328429.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 934590.00
CBAV.MC income_statement (annual, 2023-12-31) — Basic Average Shares: 16303008.00
CBAV.MC income_statement (annual, 2023-12-31) — Basic EPS: 2.21
CBAV.MC cash_flow (annual, 2023-12-31) — Beginning Cash Position: 19172895.00
CBAV.MC cash_flow (annual, 2023-12-31) — Capital Expenditure: -22678503.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 44752443.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Capital Stock: 1630758.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 8306482.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 51240756.00
CBAV.MC cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -13571479.00
CBAV.MC cash_flow (annual, 2023-12-31) — Change In Inventory: -311929.00
CBAV.MC cash_flow (annual, 2023-12-31) — Change In Payable: 2502319.00
CBAV.MC cash_flow (annual, 2023-12-31) — Change In Receivables: -433437.00
CBAV.MC cash_flow (annual, 2023-12-31) — Change In Working Capital: 1756953.00
CBAV.MC cash_flow (annual, 2023-12-31) — Changes In Cash: -10866414.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Common Stock: 1630758.00
CBAV.MC cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -13571479.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Common Stock Equity: 90996308.00
CBAV.MC cash_flow (annual, 2023-12-31) — Common Stock Issuance: 711127.00
CBAV.MC cash_flow (annual, 2023-12-31) — Common Stock Payments: -706492.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Construction In Progress: 6370032.00
CBAV.MC income_statement (annual, 2023-12-31) — Cost Of Revenue: 27073985.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Current Assets: 57741488.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 8639708.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Current Debt: 2115067.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 10754775.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Current Liabilities: 45265707.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Current Provisions: 343338.00
CBAV.MC cash_flow (annual, 2023-12-31) — Depreciation: 16980535.00
CBAV.MC cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 16980535.00
CBAV.MC income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 16980535.00
CBAV.MC income_statement (annual, 2023-12-31) — Depreciation Income Statement: 16980535.00
CBAV.MC income_statement (annual, 2023-12-31) — Diluted Average Shares: 16303008.00
CBAV.MC income_statement (annual, 2023-12-31) — Diluted EPS: 2.21
CBAV.MC income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 35970928.00
CBAV.MC income_statement (annual, 2023-12-31) — EBIT: 50224694.00
CBAV.MC income_statement (annual, 2023-12-31) — EBITDA: 67205229.00
CBAV.MC cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
CBAV.MC cash_flow (annual, 2023-12-31) — End Cash Position: 8306482.00
CBAV.MC cash_flow (annual, 2023-12-31) — Financing Cash Flow: -24365663.00
CBAV.MC cash_flow (annual, 2023-12-31) — Free Cash Flow: 35133612.00
CBAV.MC cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -66574.00
CBAV.MC income_statement (annual, 2023-12-31) — General And Administrative Expense: 15851533.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Goodwill: 14615838.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 17362677.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 3280267.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Gross PPE: 234148741.00
CBAV.MC income_statement (annual, 2023-12-31) — Gross Profit: 197849966.00
CBAV.MC income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 26668.00
CBAV.MC income_statement (annual, 2023-12-31) — Interest Expense: 571654.00
CBAV.MC income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 571654.00
CBAV.MC income_statement (annual, 2023-12-31) — Interest Income: 151341.00
CBAV.MC income_statement (annual, 2023-12-31) — Interest Income Non Operating: 151341.00
CBAV.MC cash_flow (annual, 2023-12-31) — Interest Paid Cff: -106254.00
CBAV.MC cash_flow (annual, 2023-12-31) — Interest Received Cfi: 151341.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Inventory: 2473453.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Invested Capital: 93658777.00
CBAV.MC cash_flow (annual, 2023-12-31) — Investing Cash Flow: -44312866.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 934590.00
CBAV.MC cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 711127.00
CBAV.MC cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 36112735.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Long Term Debt: 547402.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 36660137.00
CBAV.MC cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CBAV.MC cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2004322.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 92501.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Long Term Provisions: 3927349.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 113728439.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Minority Interest: 1279163.00
CBAV.MC income_statement (annual, 2023-12-31) — Minority Interests: -763410.00
CBAV.MC cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CBAV.MC cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 4635.00
CBAV.MC income_statement (annual, 2023-12-31) — Net Income: 35970928.00
CBAV.MC income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 35970928.00
CBAV.MC income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 36734338.00
CBAV.MC income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 35970928.00
CBAV.MC income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 35970928.00
CBAV.MC cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 49653040.00
CBAV.MC income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 36734338.00
CBAV.MC income_statement (annual, 2023-12-31) — Net Interest Income: -420313.00
CBAV.MC cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -21785704.00
CBAV.MC cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -2004322.00
CBAV.MC cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -2004322.00
CBAV.MC income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -420313.00
CBAV.MC cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -2178000.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Net PPE: 99059646.00
CBAV.MC cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -22678503.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 73633631.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 1403624.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 513752.00
CBAV.MC income_statement (annual, 2023-12-31) — Normalized EBITDA: 67165323.00
CBAV.MC income_statement (annual, 2023-12-31) — Normalized Income: 35941404.72
CBAV.MC cash_flow (annual, 2023-12-31) — Operating Cash Flow: 57812115.00
CBAV.MC income_statement (annual, 2023-12-31) — Operating Income: 50040691.00
CBAV.MC income_statement (annual, 2023-12-31) — Operating Revenue: 224923951.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 16302373.00
CBAV.MC cash_flow (annual, 2023-12-31) — Other Cash Adjustment Outside Changein Cash: 1.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Other Current Assets: 1014053.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 2746839.00
CBAV.MC cash_flow (annual, 2023-12-31) — Other Non Cash Items: 424548.00
CBAV.MC income_statement (annual, 2023-12-31) — Other Operating Expenses: 17463999.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Other Properties: 6723603.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Other Receivables: 61388.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 42934274.00
CBAV.MC income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Payables: 21807466.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1072936.00
CBAV.MC income_statement (annual, 2023-12-31) — Pretax Income: 49653040.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Properties: 107326667.00
CBAV.MC cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 697073.00
CBAV.MC cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CBAV.MC cash_flow (annual, 2023-12-31) — Purchase Of Investment: -40532202.00
CBAV.MC cash_flow (annual, 2023-12-31) — Purchase Of PPE: -22678503.00
CBAV.MC income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 27073985.00
CBAV.MC income_statement (annual, 2023-12-31) — Reconciled Depreciation: 16980535.00
CBAV.MC income_statement (annual, 2023-12-31) — Rent And Landing Fees: 1778097.00
CBAV.MC income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 1778097.00
CBAV.MC cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2004322.00
CBAV.MC cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -706492.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Retained Earnings: 35970928.00
CBAV.MC cash_flow (annual, 2023-12-31) — Sale Of Business: 14000.00
CBAV.MC cash_flow (annual, 2023-12-31) — Sale Of Investment: 18746498.00
CBAV.MC income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 10310772.00
CBAV.MC income_statement (annual, 2023-12-31) — Selling General And Administration: 26162305.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Share Issued: 16307580.00
CBAV.MC income_statement (annual, 2023-12-31) — Special Income Charges: -26668.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Stockholders Equity: 90996308.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Tangible Book Value: 73633631.00
CBAV.MC income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 10382.72
CBAV.MC income_statement (annual, 2023-12-31) — Tax Provision: 12918702.00
CBAV.MC income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
CBAV.MC balance_sheet (annual, 2023-12-31) — Taxes Receivable: 0.00
CBAV.MC cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -11642698.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Total Assets: 178642416.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Total Capitalization: 91543710.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Total Debt: 47414912.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 92275471.00
CBAV.MC income_statement (annual, 2023-12-31) — Total Expenses: 174883260.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 86366945.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 120900928.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 41101238.00
CBAV.MC income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 50014023.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Total Tax Payable: 6283173.00
CBAV.MC income_statement (annual, 2023-12-31) — Total Unusual Items: 39906.00
CBAV.MC income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 39906.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 5207.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Treasury Stock: 109914.00
CBAV.MC balance_sheet (annual, 2023-12-31) — Working Capital: 12475781.00
CBAV.MC cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 12120000.00
CBAV.MC balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 4417000.00
CBAV.MC balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 11113000.00
CBAV.MC income_statement (annual, 2024-12-31) — +Operating Expense: 176436359.00
CBAV.MC income_statement (annual, 2024-12-31) — +Total Revenue: 262648149.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Accounts Payable: 17173800.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Accounts Receivable: 4018900.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -141726764.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -141726764.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 4893814.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 4893814.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -400238.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -400238.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 98279.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 98279.00
CBAV.MC income_statement (annual, 2024-12-31) — Basic Average Shares: 16001440.00
CBAV.MC income_statement (annual, 2024-12-31) — Basic EPS: 2.47
CBAV.MC cash_flow (annual, 2024-12-31) — Beginning Cash Position: 8306482.00
CBAV.MC cash_flow (annual, 2024-12-31) — Capital Expenditure: -26507732.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 54132265.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 54132265.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Capital Stock: 1630758.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Capital Stock: 1630758.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 10141037.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 38578789.00
CBAV.MC cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -25890452.00
CBAV.MC cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: -150452.00
CBAV.MC cash_flow (annual, 2024-12-31) — Change In Inventory: -247238.00
CBAV.MC cash_flow (annual, 2024-12-31) — Change In Payable: -1777180.00
CBAV.MC cash_flow (annual, 2024-12-31) — Change In Receivables: 217332.00
CBAV.MC cash_flow (annual, 2024-12-31) — Change In Working Capital: -1807086.00
CBAV.MC cash_flow (annual, 2024-12-31) — Changes In Cash: 1953740.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Common Stock: 1630758.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Common Stock: 1630758.00
CBAV.MC cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -25890452.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Common Stock Equity: 96920019.00
CBAV.MC cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1431161.00
CBAV.MC cash_flow (annual, 2024-12-31) — Common Stock Payments: -10240422.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Construction In Progress: 381753.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 381753.00
CBAV.MC income_statement (annual, 2024-12-31) — Cost Of Revenue: 30563998.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Current Assets: 47723324.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 9316451.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 9316451.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Current Debt: 2013739.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Current Debt: 2013739.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 11330190.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 11330190.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Current Liabilities: 50440633.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Current Provisions: 267778.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Current Provisions: 267778.00
CBAV.MC cash_flow (annual, 2024-12-31) — Depreciation: 20880350.00
CBAV.MC cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 20880350.00
CBAV.MC income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 20880350.00
CBAV.MC income_statement (annual, 2024-12-31) — Depreciation Income Statement: 20880350.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
CBAV.MC income_statement (annual, 2024-12-31) — Diluted Average Shares: 16001440.00
CBAV.MC income_statement (annual, 2024-12-31) — Diluted EPS: 2.47
CBAV.MC income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 40205076.00
CBAV.MC income_statement (annual, 2024-12-31) — EBIT: 57209927.00
CBAV.MC income_statement (annual, 2024-12-31) — EBITDA: 78090277.00
CBAV.MC cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -119185.00
CBAV.MC cash_flow (annual, 2024-12-31) — End Cash Position: 10141037.00
CBAV.MC cash_flow (annual, 2024-12-31) — Financing Cash Flow: -39655667.00
CBAV.MC cash_flow (annual, 2024-12-31) — Free Cash Flow: 35999434.00
CBAV.MC cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -1219421.00
CBAV.MC income_statement (annual, 2024-12-31) — General And Administrative Expense: 23322357.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Goodwill: 29007779.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Goodwill: 29007779.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 37738939.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 4419138.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 4419138.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Gross PPE: 264388399.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Gross PPE: 264388399.00
CBAV.MC income_statement (annual, 2024-12-31) — Gross Profit: 232084151.00
CBAV.MC income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: -27149.00
CBAV.MC income_statement (annual, 2024-12-31) — Interest Expense: 1218537.00
CBAV.MC income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1218537.00
CBAV.MC income_statement (annual, 2024-12-31) — Interest Income: 296490.00
CBAV.MC income_statement (annual, 2024-12-31) — Interest Income Non Operating: 296490.00
CBAV.MC cash_flow (annual, 2024-12-31) — Interest Paid Cff: -181058.00
CBAV.MC cash_flow (annual, 2024-12-31) — Interest Received Cfi: 296490.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Inventory: 3282607.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Inventory: 3282607.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Invested Capital: 106256659.00
CBAV.MC cash_flow (annual, 2024-12-31) — Investing Cash Flow: -20897759.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 98279.00
CBAV.MC cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1431161.00
CBAV.MC cash_flow (annual, 2024-12-31) — Issuance Of Debt: 7200000.00
CBAV.MC cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 44815814.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 44815814.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Long Term Debt: 7322901.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 52138715.00
CBAV.MC cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 7200000.00
CBAV.MC cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
CBAV.MC cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2516101.00
CBAV.MC cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -854101.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 58280.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 58280.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Long Term Provisions: 5199121.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 5199121.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 134468644.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 134468644.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Minority Interest: 1440233.00
CBAV.MC income_statement (annual, 2024-12-31) — Minority Interests: -930748.00
CBAV.MC cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -11107720.00
CBAV.MC cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 280.00
CBAV.MC cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -8809261.00
CBAV.MC income_statement (annual, 2024-12-31) — Net Income: 40205076.00
CBAV.MC income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 40205076.00
CBAV.MC income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 41135824.00
CBAV.MC income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 40205076.00
CBAV.MC income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 40205076.00
CBAV.MC cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 55991390.00
CBAV.MC income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 41135824.00
CBAV.MC income_statement (annual, 2024-12-31) — Net Interest Income: -922047.00
CBAV.MC cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 16421203.00
CBAV.MC cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 4683899.00
CBAV.MC cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -854101.00
CBAV.MC cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 4683899.00
CBAV.MC cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -854101.00
CBAV.MC income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -922047.00
CBAV.MC cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 4502000.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Net PPE: 122661635.00
CBAV.MC cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -26507732.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 59181080.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 1877500.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1613982.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1613982.00
CBAV.MC income_statement (annual, 2024-12-31) — Normalized EBITDA: 76843707.00
CBAV.MC income_statement (annual, 2024-12-31) — Normalized Income: 39289244.40
CBAV.MC cash_flow (annual, 2024-12-31) — Operating Cash Flow: 62507166.00
CBAV.MC income_statement (annual, 2024-12-31) — Operating Income: 55647792.00
CBAV.MC income_statement (annual, 2024-12-31) — Operating Revenue: 262648149.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 15993265.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Other Current Assets: 1150306.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 1150306.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Other Current Liabilities: -1.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Other Equity Interest: 507577.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 507577.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 8731160.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 8731160.00
CBAV.MC cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1257031.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 2.00
CBAV.MC income_statement (annual, 2024-12-31) — Other Operating Expenses: 19345372.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Other Payable: 7608000.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Other Properties: 7873667.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Other Properties: 7873667.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Other Receivables: 539459.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Other Receivables: 539459.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 28437752.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 28437752.00
CBAV.MC income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Payables: 23698199.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1215578.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1215578.00
CBAV.MC income_statement (annual, 2024-12-31) — Pretax Income: 55991390.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Properties: 121664335.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Properties: 121664335.00
CBAV.MC cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 446716.00
CBAV.MC cash_flow (annual, 2024-12-31) — Purchase Of Business: -11107720.00
CBAV.MC cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 280.00
CBAV.MC cash_flow (annual, 2024-12-31) — Purchase Of Investment: -14162563.00
CBAV.MC cash_flow (annual, 2024-12-31) — Purchase Of PPE: -26507732.00
CBAV.MC income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 30563998.00
CBAV.MC income_statement (annual, 2024-12-31) — Reconciled Depreciation: 20880350.00
CBAV.MC income_statement (annual, 2024-12-31) — Rent And Landing Fees: 1793508.00
CBAV.MC income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 1793508.00
CBAV.MC cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2516101.00
CBAV.MC cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -854101.00
CBAV.MC cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -10240422.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Retained Earnings: 40205076.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 40205076.00
CBAV.MC cash_flow (annual, 2024-12-31) — Sale Of Business: 17000.00
CBAV.MC cash_flow (annual, 2024-12-31) — Sale Of Investment: 30583766.00
CBAV.MC income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 12140356.00
CBAV.MC income_statement (annual, 2024-12-31) — Selling General And Administration: 35462713.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Share Issued: 16307580.00
CBAV.MC income_statement (annual, 2024-12-31) — Special Income Charges: 27149.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Stockholders Equity: 96920019.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Tangible Book Value: 59181080.00
CBAV.MC income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 330738.40
CBAV.MC income_statement (annual, 2024-12-31) — Tax Provision: 14855566.00
CBAV.MC income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.27
CBAV.MC balance_sheet (annual, 2024-12-31) — Taxes Receivable: 153263.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 153263.00
CBAV.MC cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -13078055.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Total Assets: 212394206.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Total Capitalization: 104242920.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Total Debt: 63468905.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 98360252.00
CBAV.MC income_statement (annual, 2024-12-31) — Total Expenses: 207000357.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 114033954.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 164670882.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 63593321.00
CBAV.MC income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 55674941.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Total Tax Payable: 6524399.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 6524399.00
CBAV.MC income_statement (annual, 2024-12-31) — Total Unusual Items: 1246570.00
CBAV.MC income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 1246570.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 314315.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Treasury Stock: 9136752.00
CBAV.MC balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 9136752.00
CBAV.MC balance_sheet (annual, 2024-12-31) — Working Capital: -2717309.00
CBAV.MC income_statement (quarterly, 2025-03-31) — +Operating Expense: 61820000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — +Total Revenue: 80216000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 21961000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 9682000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 5743000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Basic Average Shares: 16005737.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Basic EPS: 0.80
CBAV.MC cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -5148000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 54781000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 53443000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 53443000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -526000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 761000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Changes In Cash: 3615000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 110267000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Current Assets: 63125000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 53069000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 5743000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 5743000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 5743000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 16005737.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.80
CBAV.MC income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 12871000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — EBIT: 18396000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — EBITDA: 24139000.00